XENLETA® (lefamulin)
Community-Acquired Bacterial Pneumonia
ApprovedActive
Key Facts
Indication
Community-Acquired Bacterial Pneumonia
Phase
Approved
Status
Active
Company
About Meitheal Pharmaceuticals
Meitheal Pharmaceuticals is a private, commercial-stage biopharma company focused on generic injectables and biosimilars. Leveraging a partnership-driven model, it has built a diverse pipeline and product portfolio targeting therapeutic areas such as anti-infectives, oncology, diabetes, fertility, and immunology. The company emphasizes robust manufacturing, steady supply, and rapid market response to address unmet needs and improve drug affordability. Its recent expansion into biosimilars with the acquisition of YUSIMRY® and launch of products like liraglutide injection signals a strategic growth phase.
View full company profile